CV Sciences (CVSI) Enterprise Value (2010 - 2026)
CV Sciences (CVSI) posted Enterprise Value of -$309000.0 for Q1 2026, down 11.15% sequentially from -$278000.0 in Q4 2025, and up 61.95% YoY from -$190804.6 in Q1 2025.
CV Sciences (CVSI) Enterprise Value (2010 - 2026) Analysis & Trends
CV Sciences has reported Enterprise Value for 17 years, with the latest figure at -$309000.0 in Q1 2026.
- Quarterly Enterprise Value rose 61.95% year-over-year to -$309000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$309000.0 (up 61.95% YoY) and the FY2025 annual result came in at -$278000.0, up 38.77% from the prior year.
- Enterprise Value retreated to -$309000.0 in Q1 2026 per CVSI's latest filing, from -$278000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$278000.0 in Q4 2025 and troughed at -$2.4 million in Q1 2022.
- A 5-year average of -$935588.2 and a median of -$812000.0 in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value tumbled 115.55% in 2023, then surged 71.78% in 2024.
- Over 5 years, Enterprise Value stood at -$611000.0 in 2022, then sank by 115.55% to -$1.3 million in 2023, then jumped by 65.53% to -$454000.0 in 2024, then soared by 38.77% to -$278000.0 in 2025, then declined by 11.15% to -$309000.0 in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$309000.0, -$278000.0, and -$381000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | -164.00 Mn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -266,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -266,000.00 |
| Mar 31, 2026 | -309,000.00 |
| Dec 31, 2025 | -278,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Jun 30, 2025 | -886,000.00 |
| Mar 31, 2025 | -812,000.00 |
| Dec 31, 2024 | -454,000.00 |
| Sep 30, 2024 | -979,000.00 |
| Jun 30, 2024 | -477,000.00 |
| Mar 31, 2024 | -662,000.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -1.69 Mn |
| Mar 31, 2023 | -714,000.00 |
| Dec 31, 2022 | -611,000.00 |
| Sep 30, 2022 | -1.14 Mn |
| Jun 30, 2022 | -1.11 Mn |
| Mar 31, 2022 | -2.44 Mn |
| Dec 31, 2021 | -1.38 Mn |
| Jun 30, 2021 | -2.96 Mn |